These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23070243)

  • 21. Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
    Billé A; Krug LM; Woo KM; Rusch VW; Zauderer MG
    J Thorac Oncol; 2016 Feb; 11(2):249-55. PubMed ID: 26845118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
    Klikovits T; Hoda MA; Dong Y; Arns M; Baumgartner B; Errhalt P; Geltner C; Machan B; Pohl W; Hutter J; Eckmayr J; Studnicka M; Flicker M; Cerkl P; Kirchbacher K; Klepetko W
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):627-34. PubMed ID: 27457873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
    Gill RR; Yeap BY; Bueno R; Richards WG
    J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.
    Rice D; Rusch V; Pass H; Asamura H; Nakano T; Edwards J; Giroux DJ; Hasegawa S; Kernstine KH; Waller D; Rami-Porta R;
    J Thorac Oncol; 2011 Aug; 6(8):1304-12. PubMed ID: 21847060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database.
    Wang S; Ma K; Wang Q; Sun F; Shi Y; Zhan C; Jiang W
    Int J Surg; 2017 Dec; 48():92-98. PubMed ID: 29050965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.
    Pass HI; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW;
    J Thorac Oncol; 2014 Jun; 9(6):856-64. PubMed ID: 24807157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
    Nakas A; von Meyenfeldt E; Lau K; Muller S; Waller D
    Eur J Cardiothorac Surg; 2012 May; 41(5):1031-6. PubMed ID: 22219469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
    Richards WG; Godleski JJ; Yeap BY; Corson JM; Chirieac LR; Zellos L; Mujoomdar A; Jaklitsch MT; Bueno R; Sugarbaker DJ
    Cancer; 2010 Mar; 116(6):1510-7. PubMed ID: 20108310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
    Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
    J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.
    Kadota K; Villena-Vargas J; Nitadori J; Sima CS; Jones DR; Travis WD; Adusumilli PS
    Ann Surg Oncol; 2015 Sep; 22(9):3136-43. PubMed ID: 25608772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K; Sato M; Fujimura S; Sakurada A; Takahashi S; Usuda K; Kondo T; Tanita T; Handa M; Saito Y; Sagawa M
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma.
    Wolf AS; Eisele M; Giroux DJ; Gill R; Nowak AK; Bille A; Rice D; Ripley RT; Opitz I; Galateau-Salle F; Hasegawa S; Kindler HL; Pass HI; Rusch VW;
    J Thorac Oncol; 2024 Aug; 19(8):1242-1252. PubMed ID: 38309456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
    Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma.
    Pilling JE; Stewart DJ; Martin-Ucar AE; Muller S; O'Byrne KJ; Waller DA
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):497-501. PubMed ID: 15037261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the "N" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.
    Bille A; Ripley RT; Giroux DJ; Gill RR; Kindler HL; Nowak AK; Opitz I; Pass HI; Wolf A; Rice D; Rusch VW;
    J Thorac Oncol; 2024 Sep; 19(9):1326-1338. PubMed ID: 38734073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
    Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B
    J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
    Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
    Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.